The human interleukin-1 type I receptor (IL-1RI) is the signal transducing receptor for IL-1, a principal proinflammatory cytokine, which is cytotoxic to pancreatic islet beta cells. The IL-1RI gene, IL1R1, maps to chromosome 2q12. We have previously examined part of the IL1R1 promoter region and in the present study we further characterized the promoter region demarcating exon 1B and 1C by sequencing and mutation scanning. New sequence was obtained 1762 bp upstream and 1609 bp downstream the known region. Within this sequence, we identified four frequent single nucleotide polymorphisms (SNPs). PCR-based RFLP assays were established and three of the polymorphisms were typed in a Danish Type 1 (insulin-dependent) diabetes mellitus (T1DM) family collection comprising 103 simplex and 150 sib-pair affected families. Linkage was evaluated by the sib-TDT (transmission disequilibrium test). One of the polymorphisms, defined by a HinfI RFLP assay, demonstrated linkage to T1DM, P(sTDT) = 0.026. Random transmission was observed to unaffected offspring from heterozygous parents, P = 0.87. No evidence for positive linkage was seen for the other tested polymorphisms, P = 0.14 and P = 0.21, respectively. To evaluate the possible functional significance of the HinfI polymorphism, we measured circulating IL-1RI plasma level in 30 T1DM patients and in 30 control subjects -10 with each genotype in both groups. Significant differences in plasma levels in relation to genotype -independent of disease status -were found (P = 0.04). In both diabetic and non-diabetic subjects, the wt/wt genotype correlated with the highest IL-1RI plasma level, whereas the plasma levels were lowest for the mt/mt genotype. Genes and Immunity (2000) 1, 495-500.
Introduction
Interleukin 1 (IL-1) plays a central role in immune and inflammatory responses (reviewed in Dinarello 1 ) and has been proposed to be a mediator in a number of inflammatory diseases, including autoimmune endocrine diseases such as Type 1 (insulin-dependent) diabetes mellitus (T1DM).
2-4 IL-1 is cytotoxic to the insulin-producing beta cells in synergy with TNF␣ and IFN␥ in vitro. Pancreatic beta cells have been shown to be especially sensitive to IL-1 and they, compared to other cell types, require unexpectedly high concentrations of IL-1 receptor antagonist (IL-1ra) to block IL-1 induced changes in funcCorrespondence: Dr F Pociot, Steno Diabetes Center, Niels Steensensvej 2, DK-2820 Gentofte, Denmark. E-mail: fpocȰnovo.dk 2 The Danish Study Group of IDDM in Childhood. 3 The Danish IDDM Epidemiology and Genetics Group. tional activity. 5 The two forms of IL-1, IL-1␣ and IL-1␤, together with the structurally related antagonist (IL-1ra) are all distinct gene products, but bind to a common receptor composed of two type I integral membrane proteins (IL1RI and IL1RacP). 6, 7 The interleukin 1 type 1 receptor (IL1-RI) (MIM 147810) is the signal-transducing receptor for IL-1. 8 The receptor is found on most cells, including T lymphocytes and beta cells. The regulation of the IL-1 receptor gene expression is likely to play a major role in controlling the effects of IL-1 since very few receptors are required for IL-1 signalling. Although considerable progress has been made in delineating the IL-1R regulatory mechanism, our understanding of the process(es) remains incomplete.
The IL-1RI gene (IL1R1) maps to the IL-1 gene cluster on chromosome 2 (2q12-q22) together with the genes for IL-1␣ (IL1A), IL-1␤ (IL1B), IL-1 receptor antagonist (IL1RN) and the IL-1 receptor type 2 (IL1RII), as well as several IL-1 and IL-1 receptor related genes. 9, 10 The IL1R1 gene is a large and complex gene, spanning approximately 74 kb 11 and comprising 12 exons and three distinct promoters. 12, 13 The three promoters direct the transcription of three different 5Ј-UTRs, encoded by exons 1A, 1B and 1C, respectively. All three promoters lack both TATA and CAAT boxes. 13 It is presently unknown whether interindividual differences in IL1R1 expression or promoter usage are related to genetic variation within regulatory regions of the gene, though such associations have been reported in several other cytokine genes. 14 The IL-1 gene cluster has been implicated in genetic susceptibility to T1DM in several studies, but the data are controversial. We have previously reported association of a PstI polymorphism in this region to T1DM, 15 although a subsequent family-based study could not confirm this. 16 This polymorphism has also shown association to T1DM in a British data set, but not in the low risk South Indian population. 17 In the high-risk population of Finland, the polymorphism only showed association to T1DM in subjects without high-risk HLA-DR3 and DR4 haplotypes. 17 Recently, new variants in the known IL1R1 sequence have been reported, but not further characterized. [18] [19] [20] In the present study, we further characterize the promoter region demarcating exon 1B and exon 1C by sequencing and mutation scanning and also evaluated IL-1RI plasma levels in relation to identified polymorphisms.
Results
We have sequenced the flanking regions of the reported sequence of the promoter region of the IL1R1 gene (GenBank accession number U14179; Sequence data showed four possible single nucleotide polymorphisms (SNPs) in positions 701 (G to A) and 1622 (G to A) of AF302042, Figure 1a , and 976 (T to C) and 1498 (T to C) of AF302043, Figure 1b . None of these polymorphisms changed any known transcriptional regulating factor or other motifs in the sequence. The four SNPs where confirmed in a test-panel comprising family members (n = 20) of the five individuals of the test panel, and PCR-based RFLP assays were designed to allow easy testing of larger materials. The four new polymorphisms are frequent, diallelic SNPs, which change a HinfI, a PstI, an AluI and a BstF5I restriction endonuclease site, respectively.
The complete family material (see Materials and methods) was typed for the PstI, HinfI and AluI polymorphisms. In a preliminary analysis the BstF5I polymorphism showed strong linkage with the AluI and was not further characterized. All tested markers demonstrated Mendelian inheritance.
Significant linkage, P(sTDT) = 0.026 was found for the HinfI-polymorphism. Random transmission of the two alleles was demonstrated to the non-affected siblings (P = 0.87) ( Table 1) . For the PstI and AluI polymorphisms, no significant linkage to T1DM was found. Random transmission of the alleles to unaffected offspring from heterozygous parents was also found for these polymorphisms (Table 1) .
We further examined if there was linkage disequilibrium between the tested polymorphisms. 22 Each polymorphism was examined against the adjacent one, haplotypes were established and it was tested if the '1-1' haplotype was transmitted more often than what could be expected from the allelic frequencies. Strong linkage disequilibrium between the PstI and the HinfI polymorphism in the upstream sequence was observed, D = 0.18. No linkage disequilibrium could, however, be demonstrated between any of the other polymorphisms (data not shown).
To evaluate the possible functional significance of the HinfI polymorphism circulating plasma levels were determined in 30 T1DM patients and 30 control subjects -10 with each genotype in both groups. IL1-RI plasma levels were not different between T1DM patients and control subjects (P = 0.57) (mean ± s.d.: 1164.6 ± 762.8 pg/mL and 991.1 ± 763.63 pg/mL, respectively). However, stratifying for the HinfI genotype revealed a significant difference (P = 0.04) (Figure 2 ). There seemed to be an alleledose effect, since the highest IL-1RI plasma levels were seen in individuals homozygous for the wildtype allele, wt/wt, and lowest levels in individuals homozygous for the mutant allele, mt/mt (Figure 2 ). The same pattern was observed in diabetic and non-diabetic subjects, although this did not reach statistical significance (P = 0.09 and P = 0.10, respectively).
Discussion
We have de novo sequenced 1762 base pairs upstream and 1609 base pairs downstream of the reported sequence of the 5UTR of the IL1R1 gene. These regions are putative regulatory regions. 11 In the upstream sequence a Sp-1 site was found, which might be of importance in the transcriptional regulation of the gene. The IL1R1 belongs to the group of housekeeping genes, which lacks typical TATA and CAAT boxes, but have high G-C contents and can partly be regulated by Sp-1 and AP-1 sites. 11 In addition several GATA boxes are found in both the upstream and downstream sequences. GATA boxes are transcription factors and have been shown to be important in transcription of several interleukin-1 receptor-related genes. 23, 24 In mast cells, promoter activity of the IL-1RI related gene T1 has been shown to be partly dependent on GATA elements and point mutations in some of these eliminate or diminish promoter activity. 23 GATA proteins have also been shown to cooperate with other transcription factors, including Sp-1 and AP-1. 23 Another IL1RI related gene, the human ST2 gene, has in several cell types, been shown to contain four GATA elements upstream of the transcription initiation site important for transcription. 24 The regulatory role of these newly identified elements in IL1R1 transcription remains unknown. Transmission patterns of alleles (1 and 2) for each of the three polymorphisms (HinfI, PstI and AluI) to affected and unaffected offspring.
To affected offspring the sib-TDT results in a ZЈ-value and corresponding P value, whereas chi-square statistic is used to evaluate transmissions to unaffected offspring. in strong linkage disequilibrium with the AluI polymorphism. Hence, this SNP was not tested further. The three assays were applied on a Danish family material, comprising 253 families.
Results showed for one of the polymorphisms, the HinfI RFLP, a significant preferential transmission of the wt allele to the affected children (ZЈ = 1.945, P = 0.026), which is suggestive of linkage to T1DM. None of the other tested polymorphisms showed evidence for linkage (P = 0.14 (PstI) and P = 0.25 (AluI), respectively).
We also tested the degree of linkage disequilibrium in the region. Strong linkage disequilibrium between the two new upstream polymorphisms was found, indicating that they are not transmitted independently of each other. No linkage disequilibrium between these upstream polymorphisms and the previously identified PstI polymorphism 15 or between this 'old' PstI and the downstream AluI polymorphism was found.
We found large differences in plasma IL-1RI levels between individuals (range 108-3808 pg/mL). Diabetic subjects had slightly higher levels than controls, although this did not reach statistical significance (P = 0.56). This is not likely to be due to prolonged disease duration, since there was no correlation between IL-1RI plasma levels and disease duration (r = 0.24, P = 0.34, data not shown). However, when stratifying for the HinfI RFLP, significant difference was seen in plasma IL-1RI (P = 0.04). Highest levels were found in individuals with the wt/wt genotype, whereas lowest levels were found in individuals with the mt/mt genotype, (P = 0.01 for comparing these two groups) suggesting an allele-dose effect. Thus, the G to A transition in position 1622 of the 'upstream' sequence correlated with reduced plasma levels of IL-1RI protein. This effect seems to be independent of disease status, but higher levels were observed in T1DM patients, as the HinfI wt/wt genotype is more frequent in this group.
The mechanism underlying this observation is unknown and it remains to be investigated if it can be assigned to changes in the regulation of the gene. Further studies are needed to replicate the observations of this study and address the relationship between IL1R1 polymorphism and plasma protein levels.
Materials and methods

Subjects
The material comprised 253 Danish families, 103 T1DM simplex families and 150 T1DM sib-pair affected families. 25, 26 All families were unrelated, and all probands fulfilled the WHO diagnostic criteria for T1DM and were diagnosed before age 30 years. The 103 simplex families included 103 affected offspring and 112 non-affected offspring. In all 103 families both parents were available for genotyping. In the 150 sib-pair families, there were 313 affected siblings and 138 non-affected siblings. In 110 of these families both parents were available for genotyping, in 40 families only one parent was available.
For calculation of allelic frequencies in the general population genotypes of the parents to the 253 probands were used, since the real population frequency is unknown. The haplotypes of the probands were used for calculation of linkage disequilibrium. For establishing haplotypes only the informative families were used, ie where correct parental haplotypes could unambiguously be determined.
Plasma samples were collected cross-sectionally. Mean disease duration in patients at the time of sampling was mean ± s.d. years (8.9 ± 5.8). Healthy individuals from the family collection served as controls. There were no differences in mean age or gender between the patient and the control groups (P = 0.6, P = 1.0, respectively).
DNA-preparation
In the present study we have used PEP-DNA (primerextension preamplification-DNA). 27 . Genomic DNA was amplified by use of random primers as follows. Two l genomic DNA (20 g/l) were used as template. Taqpolymerase (Promega Corp, Madison, WI, USA) (5 units per sample) and 1 × PCR-buffer with 1.5 mm of MgCl 2 , 2 mm of each dATP, dCTP, dGTP and dTTP (dNTP-mix), (Gibco BRL, Life Technologies, Paisley, Scotland, UK) and 280 m Poly N primer (15-mer) (Operon Technologies, Alameda, CA, USA) were added in a total volume of 50 l. The PCR-reaction involved an initial denaturing phase of 3 min at 94°, followed by 50 cycles of denaturing at 94°for 1 min, annealing at 37°for 2 min, 37-55°ramp-ing (10 s per degree) and extension at 55°for 4 min. In the end a final extension for 5 min at 72°was used. The resulting PCR-products were diluted 1+14 in TE-buffer. For all PCR's in this study, GeneAmp PCR system 9700 (PE Biosystems, Foster City, CA, USA) was used. The quality of this DNA-preparation has been thoroughly tested in our laboratory. In more than 30 different assays absolute agreement with data obtained from genomic DNA-based assays was observed (Pociot et al, unpublished data).
Sequencing PCR-products were purified by Ultrafree-MC (Millipore, Bedford, MA, USA) and sequenced directly on a ABI PRISM 310 Genetic Analyzer using Big Dye chemistry (PE Biosystems). Primer-sequences for sequencing were based on clones derived from a human placental library, 15 a kind gift from Charles A Dinarello, Denver, CO, USA.
Sequence alignment was done using the Sequencer 3.1.1 Software (Gene Codes Corporation, Ann Arbor, MI, USA).
PstI RFLP assay A PCR-based RFLP assay was established using the following primers: 5Ј-TTGCTATGACCCTGGTGGTGT-3Ј and 5Ј-AAATCCTGGTGTGTTAGGCCA-3Ј. Three l PEP-DNA was used for PCR in a total volume of 20 l. The PCR-mixture contained, in addition 1 unit Taq polymerase in 1 × PCR-buffer (Gibco BRL), 1 m of each primer, 50 m of dNTP, 2 mm MgCl 2 , and 9.1 l H 2 O. Denaturing, annealing and extension temperatures of 95°, 62°and 72°, respectively, for 30, 60 and 90 seconds in a total of 35 cycles were used, followed by a final extension at 72°for 10 min. The resulting PCR products were digested with 5 units PstI-enzyme (Promega) for 8 h and analysed by gel-electrophoresis in a 2% agarose gel.
HinfI RFLP assay An assay was established using the following primers: 5Ј-CAGGGATGACAGTCTCCACCTT-3Ј and 5Ј-GTG TCCAAATGGCAGTTCTGAA-3Ј. Three l PEP-DNA were used for PCR in a total volume of 20 l. The PCRmixture further contained 1 unit Taq polymerase in 1 × PCR-buffer (Gibco BRL), 1 m of each primer, 50 m of dNTP, 1.5 mm MgCl 2 , and 9.3 l H 2 O. Denaturing, annealing and extension temperatures of 95°, 64°and 72°, respectively, for 30, 45 and 90 seconds in a total of 35 cycles were used, followed by a final extension at 72°for 10 min. Three units HinfI-enzyme (New England Biolabs, Beverly, MA, USA) were used to digest the PCR products for 8 h and finally the products were analysed by gelelectrophoresis in a 2% agarose gel.
AluI RFLP assay A similar assay was set up to detect the polymorphic AluI site, using the following primers: 5Ј-TGATCTGAATT CTCACATGACCTTG-3Ј and 5Ј-GGCACCACAAACTT GGAGAATAG-3Ј. For this PCR reaction three l PEP-DNA, 1 unit Taq polymerase in 1 × PCR-buffer (Gibco BRL), 1 m of each primer, 50 m of dNTP, 1.5 mm MgCl 2 , and 9.3 l H 2 O in a total volume of 20 l were used. Denaturing, annealing and extension temperatures of 95°, 64°and 72°, respectively, for 30, 45 and 90 seconds in a total of 35 cycles were used, followed by a final extension at 72°for 10 min. The PCR products were digested with 3 units AluI-enzyme (Promega) for 8 h and analysed by gel-electrophoresis in a 2% agarose gel.
IL-1RI ELISA
Plasma levels of IL-1RI were measured by sandwich ELISA using antibodies and calibration protein from RnD Systems. Between each of the five steps the immunoplates (Nunc, Maxisorp F96, Denmark) were washed four times in 300 L per well of washing solution (0.15 M NaCl with 0.05% Tween) using a Denley Wellwash 4 (Denley Instruments LTD, West Sussex, UK). Immunoplates were coated with 100 L per well 4 g/mL monoclonal anti-human IL-1R1 capture antibody (RnD Systems, UK) diluted in PBS and incubated overnight at 4°C. Then calibration (protein from RnD Systems) and unknown sample were diluted 1+1 in RPMI 1640 with 20 mM HEPES, 1% Triton X-100, 0.2% gelatine and 1% TWEEN 20. After dilution the samples were applied in duplicates (100 L per well) to the immunoplates. The immunoplates were incubated for 2 h on a horizontal shaker (400 osc/min) at room temperature. Then 100 L per well 100 ng/mL biotinylated detection antibody (RnD Systems) diluted in TBS (20 mm Tris(base), 150 mm NaCl, pH 7.3) with 0.1% BSA and 0.05% TWEEN 20 was added and incubated for 2 h at room temperature. Immunoplates were incubated with 100 L per well 0.05 g/mL Streptavidin-peroxidase (Sigma) diluted in PBS with 0.05% TWEEN 20 for 20 min at room temperature. One hundred L of enzyme substrate (TMB ready-to-use substrate solution (KEM-EN-TEC, Denmark)) was added to each well and incubated 20-30 min at room temperature in darkness. The colour reaction was stopped by adding 100 L 0.2 M H 2 SO 4 to each well. The absorbance was measured at 450 nm (ref 620 nm) using an immunoreader (Spectra II SLT: Wallac, Turku, Finland). Calculations were performed using the Multicalc Advanced Softeware (Wallac). The working range of the assay was 70-2000 pg/mL. Intra-and inter-assay coefficients of variation calculated from three points on the calibration curve were as follows: 240 pg/mL: 7.25 and 0.15%; 500 pg/mL: 8.65 and 1.16%; 2000 pg/mL; 10.6 and 2.05%. All samples were measured twice in duplicate. Mean of the two measurements was used for the data analysis.
Statistics
For comparison of allelic frequencies chi-square statistics were used. For Sib-TDT a ZЈ-score and corresponding Pvalues were calculated. 28 Linkage disequilibrium was calculated by the method of Devlin and Risch. 22 D-values close to zero indicates no linkage disequilibrium, whereas values approaching −0.25 or +0.25 are suggestive of strong linkage disequilibrium. For comparison of plasma IL-1RI levels Mann-Whitney or Kruskal-Wallis nonparametric tests were used. Two-tailed P-values of less than 0.05 were considered significantly. Spearman's test was used for correlation analysis. Linkage disequilibrium between the identified SNPs suggested they were not unrelated, thus P-values were not corrected for number of comparisons. Data analysis between groups were performed using the InStat 2.03 Statistical Software (GraphPad Software, MA, USA).
URLs for data in this study are as follows: MatInspector, http://www.gsf.de/cgi-bin/matsearch.pl GenBank, http://www.ncbi.nlm.gov/Genbank/ New sequences have been submitted to GenBank: accession numbers AF302042 and AF302043.
